Articles

Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells

Division of Hematology and Clinical Immunology and Bone Marrow Transplantation Program, Department of Medicine, University of Perugia, Italy
Division of Hematology and Clinical Immunology and Bone Marrow Transplantation Program, Department of Medicine, University of Perugia, Italy
Innate Pharma, Marseille, France
Division of Hematology and Clinical Immunology and Bone Marrow Transplantation Program, Department of Medicine, University of Perugia, Italy
Division of Hematology and Clinical Immunology and Bone Marrow Transplantation Program, Department of Medicine, University of Perugia, Italy
Division of Hematology and Clinical Immunology and Bone Marrow Transplantation Program, Department of Medicine, University of Perugia, Italy
Innate Pharma, Marseille, France
Division of Hematology and Clinical Immunology and Bone Marrow Transplantation Program, Department of Medicine, University of Perugia, Italy
Division of Immunology, University of Marseille, France
Innate Pharma, Marseille, France
Division of Hematology and Clinical Immunology and Bone Marrow Transplantation Program, Department of Medicine, University of Perugia, Italy
Vol. 101 No. 5 (2016): May, 2016 https://doi.org/10.3324/haematol.2015.135301